We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6273:TSESMC Corporation Analysis

Data as of 2026-06-07 - not real-time

¥65,260.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SMC Corp currently trades at ¥65,260, sitting above its 20‑day SMA of ¥69,506 and 50‑day SMA of ¥69,194, but still below the 200‑day SMA of ¥59,290, indicating a short‑term bullish alignment within a longer‑term uptrend. The RSI of 42 suggests modest momentum, while the MACD shows a bearish divergence (line below signal, negative histogram), tempering enthusiasm. Volume has been decreasing, and the stock is trading comfortably above the identified support at ¥63,160 with ample headroom to the 52‑week high of ¥86,800. Nonetheless, the Fear & Greed index reads Extreme Greed (83.02), hinting at possible market over‑optimism.
Fundamentally, SMC delivers solid growth – revenue up 15.4% YoY, gross margin near 45% and operating margin over 22% – and trades at a forward PE of 19.9, well below the industry average of 30.2, supporting a value case. The DCF‑derived fair value of ¥63,591 is slightly under the market price, suggesting limited upside, yet the model’s upside/downside metric of +20% leaves room for appreciation. With a dividend yield of 1.53% and a payout ratio under 40%, the dividend appears sustainable, reinforced by a strong cash position and low debt‑to‑equity of 0.24. Low beta (0.61) and moderate volatility (63% 30‑day) combine to give a balanced risk profile, making SMC a compelling candidate for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish SMA alignment indicating short‑term strength
  • Bearish MACD divergence warning of potential pullback
  • Decreasing volume suggests waning momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 15% and strong margins
  • Forward PE of 19.9 vs industry 30.2 signals valuation appeal
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low debt-to-equity and robust cash reserves
  • Stable industry exposure with diversified end‑markets
  • Long‑term upside potential of ~20% despite current price premium

Key Metrics & Analysis

Financial Health

Revenue Growth15.40%
Profit Margin19.86%
P/E Ratio24.7
ROE8.27%
ROA5.40%
Debt/Equity0.24
P/B Ratio1.9
Op. Cash Flow¥188.9B
Free Cash Flow¥-37073125376
Industry P/E30.2

Technical Analysis

TrendBullish
RSI41.9
Support¥63,160.00
Resistance¥86,800.00
MA 20¥69,506.00
MA 50¥69,193.60
MA 200¥59,290.15
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Fair Value¥63,590.81
Target Price¥78,400.00
Upside/Downside20.13%
GradeFair
TypeBlend
Dividend Yield1.53%

Risk Assessment

Beta0.61
Volatility63.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.